Michael Jacobsen
Director of Finance/CFO bei OMEROS CORPORATION
Vermögen: 48 300 $ am 31.03.2024
Profil
Michael A.
Jacobsen is currently the Chief Accounting Officer, Treasurer & VP at Omeros Corp.
He previously worked as the Senior Director-Finance & Corporate Controller at ICOS Corp.
and as the Chief Accounting Officer & Vice President at ZymoGenetics, Inc. He also served as the Secretary, Chief Accounting Officer & VP-Finance at Sarepta Therapeutics, Inc. from 2012 to 2013.
Jacobsen received his undergraduate degree from Idaho State University in 1980.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
OMEROS CORPORATION
0,02% | 22.09.2023 | 14 000 ( 0,02% ) | 48 300 $ | 31.03.2024 |
Aktive Positionen von Michael Jacobsen
Unternehmen | Position | Beginn |
---|---|---|
OMEROS CORPORATION | Director of Finance/CFO | 01.08.2013 |
Ehemalige bekannte Positionen von Michael Jacobsen
Unternehmen | Position | Ende |
---|---|---|
SAREPTA THERAPEUTICS, INC. | Director of Finance/CFO | 15.11.2011 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Chief Operating Officer | 01.08.2011 |
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Director of Finance/CFO | - |
Ausbildung von Michael Jacobsen
Idaho State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
SAREPTA THERAPEUTICS, INC. | Health Technology |
OMEROS CORPORATION | Health Technology |
Private Unternehmen | 2 |
---|---|
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Health Technology |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |